Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Total Debt / EBITDA

Intercept Pharmaceuticals Total Debt / EBITDA Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Total Debt / EBITDA from 2011 to 2020.
  • Intercept Pharmaceuticals Total Debt / EBITDA for the quarter ending June 06, 2020 was $-3m a 37.03% decrease of -1m year over year
  • Intercept Pharmaceuticals Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $-2m a 5.61% decrease of 0m year over year
  • Intercept Pharmaceuticals Annual Total Debt / EBITDA for 2019 was $-2m a 27.53% decrease of -1m from 2018
  • Intercept Pharmaceuticals Annual Total Debt / EBITDA for 2018 was $-1m a 17.40% decrease of 0m from 2017
  • Intercept Pharmaceuticals Annual Total Debt / EBITDA for 2017 was $-1m a 11.60% decrease of 0m from 2016
Other Ratios Metrics:
  • Intercept Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $71m a -34.16% decrease of -24m year over year
  • Intercept Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $5m a -50.16% decrease of -3m year over year
  • Intercept Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $248m a -27.17% decrease of -67m year over year
View Chart On Koyfin

Quarterly ICPT Total Debt / EBITDA Data

06/2020$-3m
03/2020$-2m
12/2019$-2m
09/2019$-2m
06/2019$-2m
03/2019$-1m
12/2018$-1m
09/2018$-2m
06/2018$-1m
03/2018$-1m

Annual ICPT Total Debt / EBITDA Data

2019$-2m
2018$-1m
2017$-1m
2016$-1m
2011$0m
2010$0m